Navigation Links
PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
Date:9/17/2009

asset 997,000 - Research and development costs 2,791,000 2,732,000 --------- --------- Total operating expenses 8,240,000 7,753,000 --------- --------- (Loss) Income from operations (1,492,000) 456,000 Other: Other (expense), net - (9,000) Royalty income 14,000 35,000 Interest income 2,000 17,000 Interest (expense) (228,000) (181,000) -------- -------- Total (212,000) (138,000) -------- -------- (Loss) Income before provision for income taxes (1,704,000) 318,000 Benefit (Provision) for Income Taxes 1,100,000 (1,000) Allowance for deferred tax asset (2,241,000) - ----------- --- Total Provision for Income taxes (1,141,000) (1,000) ----------- ------ Net (Loss) Income $(2,845,000) $317,000 ----------- -------- Net (Loss) Income per share: Basic $(0.29) $0.03 ------ ----- Diluted $(0.29) $0.03
'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Provides Updates on Key Developments
5. American Pacific Announces Executive Change
6. United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists
7. Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants
8. AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media
9. SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test
10. Neogen Corporation Announces 1st Quarter Results Conference Call
11. MDS Announces CEO Transition Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Vivakor Announces New Acquisition Strategy 2Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2Public Opinion on Health Reform Stable and Supportive as Debate Heats Up But Moveable Too 48983 1Public Opinion on Health Reform Stable and Supportive as Debate Heats Up But Moveable Too 48983 2Public Opinion on Health Reform Stable and Supportive as Debate Heats Up But Moveable Too 48983 3Public Opinion on Health Reform Stable and Supportive as Debate Heats Up But Moveable Too 48983 4Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 1Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 4Why do we choose our mates 3F Ask Charles Darwin prof says 8848 1Why do we choose our mates 3F Ask Charles Darwin prof says 8848 2